Search research articles
Contact Us
Filters
Showing results (31-40 of 75) with videos related to
Page
of 8
Sort By:
Bone Marrow Transplantation
|
March 31, 2026
Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT
Nico Gagelmann, Maximilian Merz, Laurien G A Baaij, et al.
Life Sciences
|
December 26, 2021
A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma
Rebecca Amet, Viola Previtali, Helene B Mihigo, et al.
Blood
|
November 20, 2008
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling
Marc S Raab, Iris Breitkreutz, Giovanni Tonon, et al.
Plos One
|
February 24, 2015
Phenotypic responses of differentiated asthmatic human airway epithelial cultures to rhinovirus
Jianwu Bai, Steven L Smock, George R Jackson, et al.
Bone Marrow Transplantation
|
June 3, 2026
Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee
Alessandro Criscimanna, Jacques-Emanuel Galimard, Isabel Sánchez-Ortega, et al.
Human Molecular Genetics
|
September 29, 2007
Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma
Patrick J Hayden, Prerna Tewari, Derek W Morris, et al.
British Journal of Haematology
|
July 21, 2011
Genetic variation at the 8q24 locus confers risk to multiple myeloma
Prerna Tewari, Anthony W Ryan, Patrick J Hayden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib
Melissa G Ooi, Patrick J Hayden, Vassiliki Kotoula, et al.
Cancer Research
|
September 4, 2012
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivo
Marc S Raab, Iris Breitkreutz, Simon Anderhub, et al.
British Journal of Haematology
|
June 3, 2022
Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis
Bhagirathbhai Dholaria, Aleksandar Radujkovic, Noel Estrada-Merly, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 75) with videos related to
Sort By:
Page
of 8
Bone Marrow Transplantation
|
March 31, 2026
Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT
Nico Gagelmann, Maximilian Merz, Laurien G A Baaij, et al.
Life Sciences
|
December 26, 2021
A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma
Rebecca Amet, Viola Previtali, Helene B Mihigo, et al.
Blood
|
November 20, 2008
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling
Marc S Raab, Iris Breitkreutz, Giovanni Tonon, et al.
Plos One
|
February 24, 2015
Phenotypic responses of differentiated asthmatic human airway epithelial cultures to rhinovirus
Jianwu Bai, Steven L Smock, George R Jackson, et al.
Bone Marrow Transplantation
|
June 3, 2026
Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee
Alessandro Criscimanna, Jacques-Emanuel Galimard, Isabel Sánchez-Ortega, et al.
Human Molecular Genetics
|
September 29, 2007
Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma
Patrick J Hayden, Prerna Tewari, Derek W Morris, et al.
British Journal of Haematology
|
July 21, 2011
Genetic variation at the 8q24 locus confers risk to multiple myeloma
Prerna Tewari, Anthony W Ryan, Patrick J Hayden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib
Melissa G Ooi, Patrick J Hayden, Vassiliki Kotoula, et al.
Cancer Research
|
September 4, 2012
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivo
Marc S Raab, Iris Breitkreutz, Simon Anderhub, et al.
British Journal of Haematology
|
June 3, 2022
Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis
Bhagirathbhai Dholaria, Aleksandar Radujkovic, Noel Estrada-Merly, et al.
Page
of 8